e-Therapeutics plc Holding(s) in Company (0871K)
August 23 2019 - 6:21AM
UK Regulatory
TIDMETX
RNS Number : 0871K
e-Therapeutics plc
23 August 2019
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES (i)
1. Identity of the issuer or the e-Therapeutics PLC
underlying issuer of existing shares
to which voting rights are attached:
(ii)
2 Reason for the notification (please tick the appropriate box
or boxes):
An acquisition or disposal of voting rights
An acquisition or disposal of qualifying financial instruments
which may result in the acquisition of shares already
issued to which voting rights are attached
An acquisition or disposal of instruments with similar
economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please
specify):
---------------------------------------------------------------
3. Full name of person(s) subject Rupert Labrum
to the notification obligation: (iii)
4. Full name of shareholder(s)
(if different from 3.): (iv)
--------------
5. Date of the transaction and date 22/08/2019
on which the threshold is crossed
or reached: (v)
--------------
6. Date on which issuer notified: 23/08/2019
--------------
7. Threshold(s) that is/are crossed
or
reached: (vi, vii) 5.00%
--------------
8. Notified details:
A: Voting rights attached to shares (viii, ix)
Class/type Situation previous Resulting situation after the triggering
of to the triggering transaction
shares transaction
if possible
using
the ISIN CODE
--------------------- --------------------------------------------------------
Number Number Number Number of voting % of voting rights
of of of shares rights (x)
Shares Voting
Rights
---------- --------- ----------- -------------------- ---------------------
Direct Direct Indirect Direct Indirect
(xi) (xii)
---------- --------- ----------- --------- --------- --------- ----------
GB00B2823H99 12015000 12015000 13449017 13449017 5.0%
---------- --------- ----------- --------- --------- --------- ----------
B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date (xiii) Conversion rights that rights
Period (xiv) may be
acquired if
the
instrument is
exercised/ converted.
------------- -------------- ----------------------- ------------
C: Financial Instruments with similar economic effect to Qualifying
Financial Instruments (xv, xvi)
Resulting situation after the triggering transaction
Type of financial Exercise Expiration Exercise/ Number of voting % of voting
instrument price date (xvii) Conversion rights instrument rights (xix,
period refers to xx)
(xviii)
--------- ------------- ------------ ------------------- ----------------
Nominal Delta
--------- ------------- ------------ ------------------- -------- ------
Total (A+B+C)
Number of voting rights Percentage of voting rights
----------------------------
13449017 5.0%
----------------------------
9. Chain of controlled undertakings through which the voting
rights and/or the
financial instruments are effectively held, if applicable: (xxi)
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy
holder will cease to hold:
12. Date on which proxy holder will
cease to hold voting rights:
13. Additional information:
14. Contact name: Rupert Labrum
---------------
15. Contact telephone number:
---------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
HOLEAEPDAFPNEFF
(END) Dow Jones Newswires
August 23, 2019 06:21 ET (10:21 GMT)
E-therapeutics (LSE:ETX)
Historical Stock Chart
From Apr 2024 to May 2024
E-therapeutics (LSE:ETX)
Historical Stock Chart
From May 2023 to May 2024